SG
Sikandar Gokuldas Adwani
About Sikandar Gokuldas Adwani
Data last updated:
Sikandar Gokuldas Adwani is a Director at Savans Superspeciality Health Care Private Limited (since 2014) and Director at Prabhusavans Private Limited (since 2023). The companies operate in Healthcare. The largest current company by reported revenue is Savans Superspeciality Health Care Private Limited at ₹17.84 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Nov 2014 | 2014 | ₹17.84 Cr (FY 2025) | Active | |
| Director | 06 Jan 2023 | 2023 | Active |
Board colleagues of Sikandar Gokuldas Adwani
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sikandar Gokuldas Adwani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sikandar Gokuldas Adwani
Sikandar Gokuldas Adwani currently holds 2 directorships: Savans Superspeciality Health Care Private Limited (Director, since 05 Nov 2014, revenue ₹17.84 Cr (FY 2025)); Prabhusavans Private Limited (Director, since 06 Jan 2023).
Sikandar Gokuldas Adwani was first appointed on 05 Nov 2014 as Director at Savans Superspeciality Health Care Private Limited. The most recent appointment on record is 06 Jan 2023 at Prabhusavans Private Limited.
The current boards of Sikandar Gokuldas Adwani's companies include Anand Balkisan Kakani (Savans Superspeciality Health Care Private Limited), Anuradha Anand Kakani (Savans Superspeciality Health Care Private Limited), Madhuri Pavan Agrawal (Savans Superspeciality Health Care Private Limited), Pavan Subhashchandra Agrawal (Savans Superspeciality Health Care Private Limited), Seema Sikandar Adwani (Savans Superspeciality Health Care Private Limited), Akshay Gopal Chandurkar (Prabhusavans Private Limited), among others.